Andrew Smith
About Andrew Smith
Andrew Smith is the Director of US Oncology Marketing for Melanoma at Bristol Myers Squibb, with over a decade of experience in various marketing and sales roles within the company.
Current Position at Bristol Myers Squibb
Andrew Smith is currently the Director of US Oncology Marketing for Melanoma at Bristol Myers Squibb. He has held this position since July 2020, leading marketing efforts specifically for melanoma. His role includes overseeing strategic marketing initiatives and implementing campaigns to effectively position the company’s oncology products in the marketplace.
Previous Roles at Bristol Myers Squibb
Andrew Smith has a substantial history with Bristol Myers Squibb. Before assuming his current role, he worked as a District Business Manager for Immuno-oncology from 2018 to 2020. From 2016 to 2018, he served as the Senior Product Manager for Opdivo US Marketing, focusing on lung cancer. His earlier roles include Community Oncology Specialist (2014-2016), Product Manager in Plainsboro, NJ (2012-2014), and Associate Product Manager (2011-2012).
Market Research and Early Career
Andrew Smith has a diverse background in market research and sales analysis. He worked as a Market Research Consultant at Carrie Beam Consulting from 2008 to 2010. Concurrently, he held a position as a Sales/Marketing Business Analyst at Bristol-Myers Squibb in Princeton, New Jersey. Before these roles, he worked as a Marketing/Sales Analyst at CPM Wolverine Proctor LLC from 2007 to 2008.
Educational Background
Andrew Smith graduated from Penn State University with a Bachelor of Science in Marketing. He completed his degree from 2004 to 2008, equipping him with a strong foundation in marketing principles that he has utilized throughout his career.
Decade-Long Experience in Oncology Marketing
Andrew Smith has accumulated over a decade of experience at Bristol Myers Squibb, specializing in oncology marketing. His roles have given him extensive expertise in melanoma and immuno-oncology. His experience spans various stages of product management and marketing, reflecting his deep understanding of the oncology market.